Malmö University Publications
Change search
Link to record
Permanent link

Direct link
Eriksson, Tommy, ProfessorORCID iD iconorcid.org/0000-0001-9437-4334
Alternative names
Publications (10 of 21) Show all publications
Al Musawi, A., Hellström, L., Axelsson, M., Midlöv, P., Rämgård, M., Cheng, Y. & Eriksson, T. (2024). Intervention for a correct medication list and medication use in older adults: a non-randomised feasibility study among inpatients and residents during care transitions. International Journal of Clinical Pharmacy
Open this publication in new window or tab >>Intervention for a correct medication list and medication use in older adults: a non-randomised feasibility study among inpatients and residents during care transitions
Show others...
2024 (English)In: International Journal of Clinical Pharmacy, ISSN 2210-7703, E-ISSN 2210-7711Article in journal (Refereed) Epub ahead of print
Abstract [en]

Background Medication discrepancies in care transitions and medication non-adherence are problematic. Few interventions consider the entire process, from the hospital to the patient’s medication use at home.

Aim In preparation for randomised controlled trials (RCTs), this study aimed (1) to investigate the feasibility of recruitment and retention of patients and data collection to reduce medication discrepancies at discharge and improve medication adherence and (2) to explore the outcomes of the interventions.

Method Participants were recruited from a hospital and a residential area. Hospital patients participated in a pharmacist-led intervention to establish a correct medication list upon discharge and a follow-up interview two weeks post-discharge. All participants received a person-centred adherence intervention for three to six months. Discrepancies in the medication lists, the Beliefs about Medicines Questionnaire (BMQ-S), and the Medication Adherence Report Scale (MARS-5) were assessed.

Results Of 87 asked to participate, 35 were included, and 12 completed the study. Identifying discrepancies, discussing discrepancies with physicians, and performing follow-up interviews were possible. Conducting the adherence intervention was also possible using individual health plans for medication use. Among the seven hospital patients, 24 discrepancies were found. Discharging physicians agreed that all discrepancies were errors, but only ten were corrected in the discharge information. Ten participants decreased their total BMQ-S concern scores, and seven increased their total MARS-5 scores.

Conclusion Based on this study, conducting the two RCTs separately may increase the inclusion rate. Data collection was feasible. Both interventions were feasible in many aspects but need to be optimised in upcoming RCTs.

Place, publisher, year, edition, pages
Springer Nature, 2024
National Category
Social and Clinical Pharmacy
Research subject
Health and society
Identifiers
urn:nbn:se:mau:diva-66018 (URN)10.1007/s11096-024-01702-4 (DOI)001159736600001 ()2-s2.0-85184470244 (Scopus ID)
Funder
Malmö University
Available from: 2024-02-16 Created: 2024-02-16 Last updated: 2024-02-26Bibliographically approved
Eriksson, T. & Midlöv, P. (Eds.). (2023). Farmakologi och farmakoterapi (1:1ed.). Lund: Studentlitteratur AB
Open this publication in new window or tab >>Farmakologi och farmakoterapi
2023 (Swedish)Collection (editor) (Other (popular science, discussion, etc.))
Abstract [sv]

Ordination av läkemedel börjar oftast hos en läkare och då inleds en komplex process där flera olika professioner, framför allt sjuksköterskor och farmaceuter, bidrar med sin kompetens till en helhetssyn för att optimera läkemedelsbehandling. Detta är fokus i denna bok, Farmakologi och farmakoterapi. Här presenteras den teoretiska bakgrunden som ger förståelse i hur läkemedel omsätts och fungerar i kroppen, men även farmakoterapi (läkemedelsbehandling) och vanliga läkemedelsrelaterade problem beskrivs. Boken är uppdelad i tre delar. Den första delen beskriver olika aspekter på praktisk läkemedelsanvändning i vården och av patienten. Speciellt fokus läggs på utvärdering av läkemedelsbehandling och samarbete mellan vårdens olika professioner. Den andra delen beskriver basalfarmakologiska principer och tillämpningar där teori och praktiska utföranden varvas. Del tre är uppbyggd enligt ATC-systemet och fokuserar på farmakoterapi vid olika sjukdomstillstånd där rekommendationer samt nytta och eventuella risker med läkemedel beskrivs. Boken vänder sig till studenter på sjuksköterskeprogrammet och till yrkesverksamma sjuksköterskor. Den kan även användas av andra professioner inom hälso- och sjukvården, såväl i undervisning som i informationssökande.

Place, publisher, year, edition, pages
Lund: Studentlitteratur AB, 2023. p. 622 Edition: 1:1
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:mau:diva-62119 (URN)9789144160788 (ISBN)
Available from: 2023-08-25 Created: 2023-08-25 Last updated: 2023-09-05Bibliographically approved
Polidori, C. & Eriksson, T. (2023). The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1. European journal of hospital pharmacy. Science and practice, 30(4), 187-187
Open this publication in new window or tab >>The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1
2023 (English)In: European journal of hospital pharmacy. Science and practice, ISSN 2047-9956, E-ISSN 2047-9964, Vol. 30, no 4, p. 187-187Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
CLINICAL MEDICINE, Clinical Competence, Clinical Laboratory Techniques, Clinical Trial, Critical Care
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:mau:diva-61381 (URN)10.1136/ejhpharm-2023-003850 (DOI)001009716600001 ()37286310 (PubMedID)2-s2.0-85164429773 (Scopus ID)
Available from: 2023-06-26 Created: 2023-06-26 Last updated: 2024-04-10Bibliographically approved
Eriksson, T. & Polidori, C. (2023). The Granada Statements: An opportunity for the hospital pharmacist to make more impact in the publication world, part 2. European journal of hospital pharmacy. Science and practice, 30(6), 309-309
Open this publication in new window or tab >>The Granada Statements: An opportunity for the hospital pharmacist to make more impact in the publication world, part 2
2023 (English)In: European journal of hospital pharmacy. Science and practice, ISSN 2047-9956, E-ISSN 2047-9964, Vol. 30, no 6, p. 309-309Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:mau:diva-61914 (URN)10.1136/ejhpharm-2023-003858 (DOI)001025127300001 ()37399272 (PubMedID)2-s2.0-85169880423 (Scopus ID)
Available from: 2023-08-16 Created: 2023-08-16 Last updated: 2023-11-10Bibliographically approved
Östbring, M. J., Petersson, G., Eriksson, T. & Hellström, L. (2022). A pharmaceutical care intervention increased adherence seemingly through an effect on beliefs about medicines. International Journal of Clinical Pharmacy, 44(1), 293-294
Open this publication in new window or tab >>A pharmaceutical care intervention increased adherence seemingly through an effect on beliefs about medicines
2022 (English)In: International Journal of Clinical Pharmacy, ISSN 2210-7703, E-ISSN 2210-7711, Vol. 44, no 1, p. 293-294Article in journal, Meeting abstract (Other academic) Published
Abstract [en]

Introduction: Beliefs about medicines is one of the strongest determinants of adherence. It’s plausible that adherence interventions can be effective by changing patients’ beliefs about medicines.

Aim: To describe how a pharmaceutical care intervention affected beliefs about medicines and adherence.

Methods: In the Motivational Interviewing and Medication review in Coronary heart disease (MIMeRiC) trial, 316 patients were randomized to a pharmaceutical care intervention during around 6 months, or standard care. Key secondary outcome was a combination of persistence (at least one refill in the period 12–16 months) and a self-report instrument at 15 months. Beliefs about medicines specific (BMQ-S) was used as a process measure.

Results: At follow up, 88% and 77% (P = 0.033) of patients were adherent in the intervention and control group respectively. Patients who had received the intervention had a more positive necessity–concern differential (NCD) than patients with standard care, 7.9 (5.7) vs. 6.3 (5.8); P = 0.022. Patients in the intervention group who were adherent had a mean NCD of 8.8 (5.6), while intervention patients who were not adherent had mean NCD 5.4 (5.5); P = 0.046. In patients receiving standard care, the mean NCD was 6.7 (5.5) and 6.3 (5.9); P = 0.746 among patients who were adherent and not adherent at follow-up.

Conclusion: The intervention seemed to increase adherence through an effect on patients’ medication beliefs.

Place, publisher, year, edition, pages
Springer, 2022
National Category
Social and Clinical Pharmacy
Identifiers
urn:nbn:se:mau:diva-50953 (URN)000760277200087 ()
Available from: 2022-04-05 Created: 2022-04-05 Last updated: 2023-06-26Bibliographically approved
Stollenwerk, M. M., Gustafsson, A., Edgren, G., Gudmundsson, P., Lindqvist, M. & Eriksson, T. (2022). Core competencies for a biomedical laboratory scientist - a Delphi study. BMC Medical Education, 22(1), Article ID 476.
Open this publication in new window or tab >>Core competencies for a biomedical laboratory scientist - a Delphi study
Show others...
2022 (English)In: BMC Medical Education, E-ISSN 1472-6920, Vol. 22, no 1, article id 476Article in journal (Refereed) Published
Abstract [en]

Background After completing university education, biomedical laboratory scientists work in clinical laboratories, in biomedical research laboratories, in biotech, and in pharmaceutical companies. Laboratory diagnostics have undergone rapid development over the recent years, with the pace showing no signs of abatement. This rapid development challenges the competence of the staff and will most certainly influence the education of future staff. This study aimed to examine what was considered the necessary competencies needed to pursue a career as a biomedical laboratory scientist. Methods A modified Delphi technique was used, with the panel of experts expressing their views in a series of three questionnaire. Consensus was defined as the point which 75 % or more of the panel participants agreed that a particular competency was necessary. Results The study highlights the perceived importance of mostly generic competencies that relate to quality, quality assurance, and accuracy, as well as different aspects of safety, respect, trustworthiness (towards patients/clients and colleagues), and communication skills. The results also stress the significance of self-awareness and professionality. Conclusions We identified important competencies for biomedical laboratory scientists. Together with complementary information from other sources, i.e., guidelines, laws, and scientific publications, the competencies identified can be used as learning outcomes in a competency-based education to provide students with all the competencies needed to work as professional biomedical laboratory scientists.

Place, publisher, year, edition, pages
BMC, 2022
Keywords
Core curriculum, Core competencies, Delphi, Biomedical laboratory scientists, Student, Expert group, Biomedical laboratory scientist degree
National Category
Biomedical Laboratory Science/Technology Learning
Identifiers
urn:nbn:se:mau:diva-54091 (URN)10.1186/s12909-022-03509-1 (DOI)000813777600002 ()35725406 (PubMedID)2-s2.0-85132263019 (Scopus ID)
Available from: 2022-08-02 Created: 2022-08-02 Last updated: 2024-02-05Bibliographically approved
Kragh, A., Eriksson, T. & Midlöv, P. (2022). Äldres läkemedelsbehandling: orsaker och risker vid multimedicinering (3ed.). Lund: Studentlitteratur AB
Open this publication in new window or tab >>Äldres läkemedelsbehandling: orsaker och risker vid multimedicinering
2022 (Swedish)Book (Other academic)
Place, publisher, year, edition, pages
Lund: Studentlitteratur AB, 2022. p. 272 Edition: 3
Keywords
Äldre, läkemedel, behandling, orsak, risker
National Category
Medicinal Chemistry
Identifiers
urn:nbn:se:mau:diva-56181 (URN)978-91-44-15923-2 (ISBN)
Available from: 2022-11-22 Created: 2022-11-22 Last updated: 2023-10-31Bibliographically approved
Eriksson, T. & Catubic Melander, A. (2021). Clinical pharmacists’ services, role and acceptance: a national Swedish survey. European journal of hospital pharmacy. Science and practice, 28(e1)
Open this publication in new window or tab >>Clinical pharmacists’ services, role and acceptance: a national Swedish survey
2021 (English)In: European journal of hospital pharmacy. Science and practice, ISSN 2047-9956, E-ISSN 2047-9964, Vol. 28, no e1Article in journal (Refereed) Published
Abstract [en]

Aim: Describe, and between regions, compare the services provided, and the pharmacists’ perceptions of their role and its importance.

Method: Online survey involving active clinical pharmacists in Sweden.

Result: The survey was completed by 118 pharmacists (66%), half of whom had at least 1 year’s formal training in clinical pharmacy, and work experience in excess of 5 years. Admission medication reconciliation and medication review are provided in most regions and often on a daily basis. The most important services were: making suggestions to physicians regarding drug changes, medication review, medication reconciliation, and patient communication. On a five-point Likert-scale (where 1 = negative and 5 = positive) very few respondents scored less than 4 on the role, acceptance and skills questions.

Discussion: Our study confirms the strong position of clinical pharmacy and clinical pharmacists in Sweden. There were some differences regarding the services provided between regions but clinical pharmacists’ patient-centred work in the clinical setting as part of the care team is well established, accepted and important. Respondents believed they could take on additional responsibilities for prescription changes without the need for further education.

Conclusion: Patient-centred clinical pharmacy work in a clinical setting as part of the care team is well established, accepted and important.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2021
National Category
Basic Medicine
Research subject
Health and society
Identifiers
urn:nbn:se:mau:diva-43779 (URN)10.1136/ejhpharm-2020-002600 (DOI)000726955800037 ()34117089 (PubMedID)2-s2.0-85107977235 (Scopus ID)
Available from: 2021-06-21 Created: 2021-06-21 Last updated: 2024-02-05Bibliographically approved
Östbring, M. J., Eriksson, T., Petersson, G. & Hellström, L. (2021). Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial. BMC Cardiovascular Disorders, 21(1), Article ID 367.
Open this publication in new window or tab >>Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial
2021 (English)In: BMC Cardiovascular Disorders, ISSN 1471-2261, E-ISSN 1471-2261, Vol. 21, no 1, article id 367Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: In the treatment of coronary heart disease, secondary prevention goals are still often unmet and poor adherence to prescribed drugs has been suggested as one of the reasons. We aimed to investigate whether pharmaceutical care by a pharmacist at the cardiology clinic trained in motivational interviewing improves clinical outcomes and patient adherence.

METHODS: This was a prospective, randomized, controlled, outcomes-blinded trial designed to compare pharmaceutical care follow-up with standard care. After standard follow-up at the cardiology clinic, patients in the intervention group were seen by a clinical pharmacist two to five times as required over seven months. Pharmacists were trained to use motivational interviewing in the consultations and they tailored their support to each patient's clinical needs and beliefs about medicines. The primary study end-point was the proportion of patients who reached the treatment goal for low-density lipoprotein cholesterol by 12 months after discharge. The key secondary outcome was patient adherence to lipid-lowering therapy at 15 months after discharge, and other secondary outcomes were the effects on patient adherence to other preventive drugs, systolic blood pressure, disease-specific quality of life, and healthcare use.

RESULTS: 316 patients were included. The proportion of patients who reached the target for low-density lipoprotein cholesterol were 37.0% in the intervention group and 44.2% in the control group (P = .263). More intervention than control patients were adherent to cholesterol-lowering drugs (88 vs 77%; P = .033) and aspirin (97 vs 91%; P = .036) but not to beta-blocking agents or renin-angiotensin-aldosterone system inhibitors.

CONCLUSIONS: Our intervention had no positive effects on risk factors for CHD, but it increased patient adherence. Further investigation of the intervention process is needed to explore the difference in results between patient adherence and medication effects. Longer follow-up of healthcare use and mortality will determine if the increased adherence per se eventually will have a meaningful effect on patient health.

TRIAL REGISTRATION: ClinicalTrials.gov NCT02102503, 03/04/2014 retrospectively registered.

Place, publisher, year, edition, pages
BioMed Central, 2021
Keywords
Coronary heart disease, Low-density lipoprotein cholesterol, Medication adherence, Medication review, Medicine management, Motivational interviewing, Pharmaceutical care, Randomized controlled trial, Secondary prevention
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:mau:diva-44830 (URN)10.1186/s12872-021-02178-0 (DOI)000679833300001 ()34334142 (PubMedID)2-s2.0-85111998744 (Scopus ID)
Available from: 2021-08-16 Created: 2021-08-16 Last updated: 2024-02-05Bibliographically approved
Hellström, L., Eriksson, T. & Bondesson, Å. (2021). Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems. European journal of hospital pharmacy. Science and practice, 28(E1), E128-E133
Open this publication in new window or tab >>Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems
2021 (English)In: European journal of hospital pharmacy. Science and practice, ISSN 2047-9956, E-ISSN 2047-9964, Vol. 28, no E1, p. E128-E133Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: The Lund Integrated Medicines Management model offers a systematic approach for individualising and optimising patient drug treatment. Clinical, economical and humanistic outcomes have been shown as well as results from the medication reconciliation process. There is a need also to describe the medication review process.

OBJECTIVE: To describe the frequency and types of drug-related problems (DRPs) identified during medication reviews and to evaluate the actions of the pharmacists and the physicians regarding the identified DRPs.

METHOD: Structured medication reviews were conducted by a multi-professional team on top of standard care for 719 patients in two internal medicine wards in a Swedish University Hospital. The medication reviews were studied retrospectively to classify DRPs and actions taken.

RESULTS: A total of 573 (80%) of patients had at least one actual DRP; an average of three DRPs per patient and in total 2164. Wrong drug and adverse drug reaction were the most common types of DRPs. The most frequent medication groups involved in DRPs were drugs for the cardiovascular system and the nervous system and the most frequent substances were warfarin, digoxin, furosemide and paracetamol. The 10 most common medications accounted for 27% of the actual DRPs. Of the identified DRPs, a total of 1740 (80%) were acted on. The three most common types of adjustments made were withdrawal of drug therapy, change of drug therapy and initiation of drug therapy. When the pharmacist suggested an adjustment, the physician implemented 88% (1037/1174) of the recommendations.

CONCLUSION: DRPs are common among elderly patients who are admitted to hospital. Systematic identification of high-risk medications and common DRP types enables targeting of prioritised patients for medication reviews.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2021
Keywords
drug-related side effects and adverse reactions, health care, hospital, medical errors, medication systems, pharmacy service, quality assurance
National Category
Social and Clinical Pharmacy
Identifiers
urn:nbn:se:mau:diva-37401 (URN)10.1136/ejhpharm-2020-002492 (DOI)000726955800025 ()33199398 (PubMedID)2-s2.0-85096441762 (Scopus ID)
Available from: 2020-12-08 Created: 2020-12-08 Last updated: 2024-02-05Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-9437-4334

Search in DiVA

Show all publications